文献速递青光眼

TXNDC5在POAG中促进细胞外基质蛋白积累并升高眼压

TXNDC5 in POAG: Promoting Extracellular Matrix Protein Accumulation and Raising Intraocular Pressure.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该研究通过无标记定量蛋白质组学筛选TGFβ2诱导的小梁网中显著上调的蛋白,发现TXNDC5通过增加TGFβ R2表达促进细胞外基质积累,并经分子伴侣介导的自噬途径降解,AR7可逆转该过程,小鼠体内敲低TXNDC5可减少ECM积累并降低眼压。

要点

  • TXNDC5通过上调TGFβ R2促进小梁网细胞外基质蛋白积累。
  • TXNDC5经分子伴侣介导的自噬途径降解,AR7可逆转TGFβ2诱导的ECM积累。
  • 小鼠体内敲低TXNDC5可减少ECM积累并降低TGFβ2诱导的高眼压。

核心结论

  • TXNDC5通过增加TGFβ R2表达促进小梁网ECM积累并升高眼压,靶向TXNDC5是POAG潜在新治疗途径。

研究设计与样本

  • 采用无标记定量蛋白质组学技术筛选TGFβ2诱导的小梁网中显著上调的蛋白,并在人小梁网细胞和小鼠中验证。

主要发现

  • 在人小梁网细胞中,TXNDC5通过增加TGFβ R2表达促进ECM积累。
  • TXNDC5通过分子伴侣介导的自噬途径降解,AR7能逆转TGFβ2诱导的小梁网ECM积累。
  • 小鼠体内实验显示,敲低TXNDC5显著减少TGFβ2诱导的小梁网组织ECM蛋白积累并降低TGFβ2诱导的高眼压。

关键数值与推荐

  • 使用自噬抑制剂CQ和蛋白合成抑制剂CHX,并调控分子伴侣介导的自噬活性以验证TXNDC5的降解途径依赖机制。

临床怎么用

  • 靶向升高TXNDC5可能成为减少POAG小梁网ECM蛋白积累的新治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Excessive accumulation of extracellular matrix (ECM) proteins in the trabecular meshwork (TM) leads to increased resistance to outflow of aqueous humor (AH) and the consequent increase in intraocular pressure (IOP) in primary open-angle glaucoma (POAG). Currently, there is no effective treatment to address this pathogenic mechanism of POAG. Therefore it is essential to screen for key proteins that are involved in TM ECM accumulation and further develop drugs targeting these mechanisms. METHODS: Proteins were screened for significant up-regulation in TGFβ2-induced TM by label-free quantitative proteomics techniques. The relationship between TXNDC5 and ECM proteins was analyzed via qPCR, Western blot, and immunohistochemistry and validated in mice. Autophagy inhibitors (CQ) and protein synthesis inhibitors (CHX) were used, and molecular chaperone-mediated autophagy (CMA) activity was modulated to validate the degradation pathway-dependent mechanism of TXNDC5. RESULTS: We confirmed that in human TM cells, TXNDC5 contributed to the accumulation of ECM by increasing the expression of TGFβ R2. We also demonstrated that TXNDC5 was degraded through the CMA pathway, and that the AR7 was able to reverse TGFβ2-induced TM ECM accumulation. Most importantly, in vivo experiments have demonstrated that knockdown of TXNDC5 significantly reduced TGFβ2-induced ECM protein accumulation in TM tissues and reduces TGFβ2-induced ocular hypertension in the mouse. CONCLUSIONS: We revealed the role and probable mechanism by which TXNDC5 leads to TM ECM accumulation and IOP elevation, suggesting that targeting elevation of TXNDC5 is a potential new therapeutic approach to reduce TM ECM protein accumulation in POAG.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Song D, Wen L, Hou M, et al. TXNDC5 in POAG: Promoting Extracellular Matrix Protein Accumulation and Raising Intraocular Pressure. Invest Ophthalmol Vis Sci. 2026. PMID: 42012274. doi:10.1167/iovs.67.4.46

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。